Seglentis: payments to doctors
Payments that named Seglentis as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1M
- Providers
- 22,334
- Transactions
- 52,725
- Average per transaction
- $20
The per-transaction average — $20 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 22,334 providers the average total is $47, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | $1,043,790 | 99.8% |
| Esteve Pharmaceuticals LLC | $2,250 | 0.2% |